Yungui Wang

11.0k total citations
63 papers, 1.3k citations indexed

About

Yungui Wang is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Yungui Wang has authored 63 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hematology, 35 papers in Molecular Biology and 13 papers in Genetics. Recurrent topics in Yungui Wang's work include Acute Myeloid Leukemia Research (29 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Yungui Wang is often cited by papers focused on Acute Myeloid Leukemia Research (29 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Yungui Wang collaborates with scholars based in China, United States and Madagascar. Yungui Wang's co-authors include Jie Jin, Jianjun Chen, Zejuan Li, Yinjun Lou, Mary Beth Neilly, Shuangli Mi, Miao Sun, Richard A. Larson, Todd R. Golub and Zhijian Qian and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Yungui Wang

61 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yungui Wang China 18 929 556 366 131 112 63 1.3k
Alissa Huston United States 16 297 0.3× 191 0.3× 274 0.7× 45 0.3× 326 2.9× 47 1.0k
Sisi Chen China 17 351 0.4× 220 0.4× 211 0.6× 106 0.8× 74 0.7× 58 989
Torstein B. Rø Norway 20 547 0.6× 93 0.2× 266 0.7× 94 0.7× 268 2.4× 44 1.2k
Tarek H. Mouhieddine United States 18 447 0.5× 287 0.5× 230 0.6× 35 0.3× 457 4.1× 61 1.2k
Mark Ross United Kingdom 20 372 0.4× 92 0.2× 97 0.3× 56 0.4× 188 1.7× 43 1.1k
Maddalena Raia Italy 20 374 0.4× 151 0.3× 121 0.3× 101 0.8× 105 0.9× 52 1.0k
Süreyya Savaşan United States 16 208 0.2× 90 0.2× 286 0.8× 88 0.7× 99 0.9× 81 943
Brett Ewald United States 12 448 0.5× 120 0.2× 73 0.2× 47 0.4× 330 2.9× 19 897
Ashis Mukhopadhyay India 13 204 0.2× 75 0.1× 118 0.3× 72 0.5× 188 1.7× 61 555
Huihui Zhao China 15 235 0.3× 110 0.2× 97 0.3× 53 0.4× 102 0.9× 49 571

Countries citing papers authored by Yungui Wang

Since Specialization
Citations

This map shows the geographic impact of Yungui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yungui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yungui Wang more than expected).

Fields of papers citing papers by Yungui Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yungui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yungui Wang. The network helps show where Yungui Wang may publish in the future.

Co-authorship network of co-authors of Yungui Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yungui Wang. A scholar is included among the top collaborators of Yungui Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yungui Wang. Yungui Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Jiajia, Yungui Wang, Shujuan Huang, et al.. (2024). High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response. Journal of Molecular Medicine. 102(3). 415–433. 5 indexed citations
2.
Shi, Ting, Mixue Xie, Li Chen, et al.. (2022). Distinct outcomes, ABL1 mutation profile, and transcriptome features between p190 and p210 transcripts in adult Philadelphia-positive acute lymphoblastic leukemia in the TKI era. Experimental Hematology and Oncology. 11(1). 13–13. 12 indexed citations
3.
Li, Fenglin, Xiang Zhang, Shihui Mao, et al.. (2021). MAP4K1 functions as a tumor promotor and drug mediator for AML via modulation of DNA damage/repair system and MAPK pathway. EBioMedicine. 69. 103441–103441. 10 indexed citations
4.
Hu, Chao, Mengxia Yu, Chenying Li, et al.. (2020). miR-550-1 functions as a tumor suppressor in acute myeloid leukemia via the hippo signaling pathway. International Journal of Biological Sciences. 16(15). 2853–2867. 14 indexed citations
5.
Huang, Shujuan, Jiajia Pan, Jing Jin, et al.. (2019). Abivertinib, a novel BTK inhibitor: Anti-Leukemia effects and synergistic efficacy with homoharringtonine in acute myeloid leukemia. Cancer Letters. 461. 132–143. 18 indexed citations
6.
Wang, Yungui, Jennifer R. Skibbe, Chao Hu, et al.. (2017). ALOX5 exhibits anti-tumor and drug-sensitizing effects in MLL-rearranged leukemia. Scientific Reports. 7(1). 1853–1853. 29 indexed citations
7.
Li, Zejuan, Ping Chen, Rui Su, et al.. (2016). PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL -Rearranged Disease. Cancer Research. 76(3). 619–629. 48 indexed citations
8.
Qin, Yongjie, Yungui Wang, & Robert E. Floden. (2016). The Effect of Problem-Based Learning on Improvement of the Medical Educational Environment: A Systematic Review and Meta-Analysis. Medical Principles and Practice. 25(6). 525–532. 45 indexed citations
9.
Huang, Hao, Xi Jiang, Jinhua Wang, et al.. (2016). Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia. Cancer Letters. 372(2). 157–165. 23 indexed citations
10.
Li, Li, Lixia Zhu, Yungui Wang, et al.. (2016). Profiling of microRNAs in AML cells following overexpression or silencing of the VEGF gene. Oncology Letters. 13(1). 105–110. 7 indexed citations
11.
Luo, Yang, Caiping Song, Hongyan Zhang, Yungui Wang, & Hao Wu. (2016). Toward sustainable and effective control: Experience of China Ebola Treatment Center in Liberia. Journal of Microbiology Immunology and Infection. 50(1). 1–3. 6 indexed citations
12.
Li, Yanan, et al.. (2015). Determination of nitrofurantion metabolite by direct competitive enzyme-linked immunosorbent assay.. Shipin anquan zhiliang jiance xuebao. 6(9). 3723–3729. 1 indexed citations
13.
Zhang, Bo, et al.. (2014). No Chemopreventive Effect of Nonsteroidal Anti-Inflammatory Drugs on Nonmelanoma Skin Cancer: Evidence from Meta-Analysis. PLoS ONE. 9(5). e96887–e96887. 18 indexed citations
14.
Xu, Weilai, Yungui Wang, Hongyan Tong, Wenbin Qian, & Jie Jin. (2014). Downregulation of hTERT: An Important As2O3 Induced Mechanism of Apoptosis in Myelodysplastic Syndrome. PLoS ONE. 9(11). e113199–e113199. 7 indexed citations
15.
16.
Mu, Qitian, Yungui Wang, Bing Chen, et al.. (2013). High expression of Musashi-2 indicates poor prognosis in adult B-cell acute lymphoblastic leukemia. Leukemia Research. 37(8). 922–927. 29 indexed citations
17.
Wang, Huafeng, Jie Jin, Yungui Wang, Xin Huang, & Jian Huang. (2013). Clonal chromosomal abnormalities in Philadelphia-negative cells in chronic myeloid leukemia patients treated with nilotinib used in first-line therapy. Annals of Hematology. 92(12). 1625–1632. 7 indexed citations
18.
Wang, Xiaoyong, et al.. (2010). Effects of ginsenoside and Lycium barbarum polysaccharide on UVB irradiation-induced premature senescence of skin fibroblasts.. Chinese Journal of Dermatology. 43(3). 184–187. 2 indexed citations
19.
Wang, Yungui, Zejuan Li, Chunjiang He, et al.. (2010). MicroRNAs expression signatures are associated with lineage and survival in acute leukemias. Blood Cells Molecules and Diseases. 44(3). 191–197. 123 indexed citations
20.
Lou, Yinjun, Jie Jin, & Yungui Wang. (2004). Triptolide inhibits transcription factor NF-kappaB and induces apoptosis of multiple myeloma cells. Leukemia Research. 29(1). 99–105. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026